designed to determine the effect of three years of treatment with rofecoxib on the risk of recurrent neoplastic polyps of the large bowel in patients with a history of colorectal adenomas
designed to determine the effect of three years of treatment with rofecoxibon the risk of recurrent neoplastic polyps of the large bowel in patients with ahistory of colorectal adenomas